<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">SSHT should be used with caution. The Korean Ministry of Food and Drug Safety permits the use of SSHT, except in the following contraindications (
 <xref rid="tbl0005" ref-type="table">Table 1</xref>)
 <xref rid="bib0215" ref-type="bibr">
  <sup>43</sup>
 </xref>: patients receiving interferon; patients with liver cirrhosis and liver cancer (use of SSHT can lead to interstitial pneumonia, which can further cause serious consequences such as death); patients with platelet counts of less than 100,000/mm
 <sup>3</sup> owing to liver dysfunction.
</p>
